Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 June 2023 | Story Belinda Janeke | Photo Kaleidoscope
Career Hub
Belinda Janeke is the Head of Career Services in the Division of Student Affairs at the University of the Free State.

Opinion article by Belinda Janeke, Head of Career Services in the Division of Student Affairs at the University of the Free State.


More than half of the youth in South Africa are unemployed. Although a tertiary qualification increases your chances of finding a job, a staggering 32,6% of graduates are still unemployed. This is unacceptably high. As universities, it is our duty to help decrease the graduate unemployment rate by producing highly employable graduates.

Employability is one of the key drivers in the University of the Free State’s (UFS) Vision 130. As an institution of higher learning, we have always supported employability and ensured that our students are skilled according to industry standards. UFS Career Services is known for cultivating relationships between the industry and students, and many successful applicants have completed our programmes before stepping into the job market. 

Coming soon:  Virtual Career Hub

This year, the Career Services Office is looking forward to technological developments in the field of career readiness. The virtual Career Hub will be a space where students and employers can make initial contact and where students can grow their employability by tracking their skills completion.

Continuous job placements

In the meantime, our newly appointed placement officers in UFS Career Services are being trained to assist students with job placements. We help students to compile a professional CV tailored to market requirements, a convincing cover letter, and a LinkedIn page that gets noticed. To make sure that students are fully prepared and confident, we also offer interview coaching and career plan development. 

We have already achieved much success with our employability support and look forward to the data that will be generated by the Career Hub. All students (from first year to postgraduates) are encouraged to connect with UFS Career Services to help increase their employability. Let your degree work for you by making sure that you are work ready.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept